← Browse by Condition
Medical Condition

eosinophilic asthma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT07323654 Phase 2
Recruiting

A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma

Enrollment
264 pts
Location
United States
Sponsor
Kymera Therapeutics, Inc.
View Trial →